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ABSTRACT 
Breast cancer is the leading cause of cancer death in women and affects hundreds of 
thousands of women and their families yearly in the United States. Having a family history of 
breast cancer is one of the strongest predictors of developing the disease. Previous studies have 
found evidence that women with a family history of breast cancer have excessive worry and 
intrusive thoughts about developing the disease and may react differently to stress than women 
who do not have a family history of breast cancer. This study uses the novel approach of measuring 
the activity of the autonomic nervous system to compare stress reactivity between women with 
and without a family history of breast cancer. 
Eighty-two women with a family history of breast cancer and 140 women without a family 
history of breast cancer who were otherwise healthy underwent a laboratory stress test. During the 
test, their heart rate variability was measured as a proxy for the activity of the autonomic nervous 
system. Repeated measures of heart rate variability were taken at baseline, the three tasks of the 
stress test, and during a recovery period. The reactivity of the two groups throughout the test were 
compared using a mixed effects ANCOVA model. One of nine heart rate variability measures 
showed significant group differences. During the stress test, women with a family history of breast 
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cancer had significantly higher levels of parasympathetic activity than women without a family 
history of breast cancer.  
Public Health Significance: The results of this study can be used to further our 
understanding of the effects of having a family history of breast cancer. 
vi 
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1.0  INTRODUCTION 
Other than skin cancer, breast cancer is the most common cancer among women in the United 
States, accounting for nearly one third of new cancer diagnoses [1]. It is the leading cause of cancer 
death for American women [1]. In 2016, it is estimated that there will be 246,660 new cases of 
breast cancer and 40,860 women will die from breast cancer [3]. One of the strongest predictors 
for breast cancer is family history of breast cancer. Having a first degree relative, (mother, sister, 
or daughter), who has had breast cancer increases a woman’s risk for developing the disease [4]. 
Multiple heritable gene mutations have been identified and linked with a higher risk of developing 
breast cancer. For example, the BRCA1 mutation is associated with a 60 - 80% lifetime risk of 
breast cancer and the BRCA2 mutation with a 40 - 60% risk [4]. It is therefore understandable that 
women with a family history of breast cancer have a higher than normal perceived risk for 
developing the disease. They also experience more worry and intrusive thoughts about it in their 
daily life [5]. Research efforts seek to quantify the effect of family history of breast cancer on 
otherwise healthy women’s lives. One particular question of interest is if women with a family 
history of breast cancer react differently to acute stress. 
A study from 2004 demonstrated that women with a family history of breast cancer had a 
higher rate of epinephrine excretion while at work and were more reactive to work stress. This 
effect was moderated by BMI, with lower BMI’s being associated with a more pronounced effect 
[6]. The more intense reaction to stress from women with a family history of breast cancer has also 
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been studied in a laboratory setting. After a 15-minute laboratory stress test involving speech and 
math tasks, women with a family history of breast cancer demonstrated a greater increase in 
distress, heart rate, natural killer cell activity and natural killer cell numbers [7]. Another study 
used the same stress test to show significant differences in epinephrine and cortisol reactivity 
between women with and without family histories of breast cancer. This study found that women 
with a family history of breast cancer had a stronger reaction to stress [8]. The current study uses 
the same laboratory stress test to compare stress reactivity between women with and without a 
family history of breast cancer by measuring their autonomic nervous system activity. 
1.1 THE AUTONOMIC NERVOUS SYSTEM AND HEART RATE VARIABILITY 
The human autonomic nervous system has two branches, the sympathetic and the parasympathetic. 
The parasympathetic nervous system maintains internal regulation while the sympathetic nervous 
system drives activities such as the fight or flight impulse. The two systems exist in a dynamic 
balance that can change rapidly in response to the surrounding environment [9]. During a stressful 
event, parasympathetic activity decreases and sympathetic activity increases. This occurs to 
minimize energy expenditure [9]. Heart rate variability (HRV), the variation in the intervals 
between consecutive heart beats, can be used to measure the activity of the sympathetic and 
parasympathetic nervous system [10]. A 1981 study demonstrated that HRV is a “sensitive, 
quantitative and noninvasive” measure of the autonomic nervous system [15].  
The following measures of HRV, which can be grouped into time domain and frequency 
domain measures, are calculated from small segments (typically two to five minutes) of an 
electrocardiograph (ECG) recording. Each of the QRS complexes is detected and the normal-to-
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normal (NN) intervals (the intervals between adjacent QRS complexes) are determined. The QRS 
complex from a continuous ECG record is shown in Figure 1 [12].  
 
 
 
Figure 1. The QRS complex from a continuous ECG record  
 
 
Time domain measures are the simplest to perform and describe aspects of the NN interval. 
When calculating time domain measures it is assumed that the correlation between adjacent time 
points is best explained by the dependence of the current value on past values [13]. The standard 
deviation of the NN intervals, SDNN, is a common time domain measure based on this interval. 
The standard deviation of the average NN interval calculated over short periods, SDANN, is 
another common time domain measure. Three time domain measures of short term variation, 
RMSSD, NN50, and pNN50, estimate high frequency variations in heart rate. RMSSD is the 
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square root of the mean squared difference of successive NN intervals, NN50 is the number of 
interval differences of successive NN intervals that are greater than 50 ms, and pNN50 is NN50 
divided by the total number of NN intervals [10]. 
Frequency domain methods measure the power spectral density (PSD) that describes how 
the power, or variance, is distributed as a function of frequency [10]. The primary characteristic of 
interest is the periodic variations found in the data. We assume that the time series we are analyzing 
is composed of periodic components that appear in proportion to their underlying variances. The 
variance associated with each periodicity of interest is evaluated separately [13]. There are three 
spectral components of interest in short-term recordings lasting roughly two to five minutes. They 
are the very low frequency (VLF), the low frequency (LF), and high frequency (HF) components 
[10]. Of particular interest are the HF component of frequencies between 0.15 and 0.40 Hz and the 
LF component of frequencies between 0.04 and 0.15 Hz. Changes in the balance between the 
sympathetic and parasympathetic nervous system are reflected in the LF and HF measures. The 
HF component is an approximate measure of parasympathetic activity while the ratio of LF to HF 
power is an approximate measure of sympathetic activity [10]. During stress when 
parasympathetic activity decreases and sympathetic activity increases, one would expect the HF 
component to decrease and the ratio of LF to HF to increase. The HF power component can also 
be measured in normalized units (nu) which represent the relative value of HF in proportion to the 
total power minus the VLF component [10]. 
The PSD can be thought of as an analogue of the probability density function (PDF). 
Similar to the PDF, the PSD is a theoretical population based concept that we can only estimate 
by sampling data. The Fast Fourier Transformation (FFT) is a commonly used non-parametric 
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method of estimating the PSD using sampled data. The FFT produces consistent estimators of the 
HF, LF, and ratio of LF to HF denoted fftHF, fftLF and fftLFoverHF [13]. 
For observed data of length T, X1,…,XT, the FFT is computed at Fourier frequencies 𝜔𝜔𝑗𝑗 =
𝑗𝑗/𝑇𝑇 for 𝑗𝑗 = 1, … ,𝑇𝑇 as  
𝑑𝑑𝑗𝑗 = 𝑇𝑇−1/2�𝑋𝑋𝑡𝑡𝑒𝑒2𝜋𝜋𝜋𝜋𝑡𝑡𝜔𝜔𝑗𝑗𝑇𝑇
𝑡𝑡=1
 
The square moduli of the FFTs, known as the periodogram,  
𝐼𝐼𝑗𝑗 = �𝑑𝑑𝑗𝑗�2 
are approximately independent and unbiased estimators of the power spectrum [13]. Consequently, 
summing periodogram values within a range of frequencies provides consistent estimators of a 
spectral component. Particularly, we consider  
fftHF = ∑ 𝐼𝐼𝑗𝑗0.15𝑇𝑇≤𝑗𝑗≤0.40𝑇𝑇  
fftLF= ∑ 𝐼𝐼𝑗𝑗0.04𝑇𝑇≤𝑗𝑗≤0.15𝑇𝑇 , 
which are consistent estimators of HF and LF, and fftLFoverHF = fftLF/fftHF, which is a 
consistent estimator of the ratio of power from low frequencies compared to high frequencies.  
1.2 RESEARCH OBJECTIVES 
This paper seeks to compare modulation of the two branches of the autonomic nervous system via 
HRV between healthy women with and without a family history of breast cancer. We use mixed 
models to compare HRV between women with and without a family history breast cancer during 
a common laboratory stress test. The results of the study can be used to further our understanding 
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of the psychological and physiological effects of having a family history of breast cancer on 
healthy women. Breast cancer is a huge burden in the U.S., not just for women who develop the 
disease but also for women who have a family history of it. Previous studies have shown the effect 
of a family history of breast cancer on women’s immune systems and stress hormone levels. This 
study can help to clarify the effects of family history of breast cancer on stress reactivity of healthy 
women. 
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2.0  METHODS 
Participants signed informed consent and completed a laboratory-based stress test. All participants 
were healthy women who either had a family history of breast cancer (FH+) or did not have a 
family history of breast cancer (FH-). There was a 10-minute baseline period (baseline) before the 
test and a 10-minute recovery session (recovery) after the stress test. During these resting periods 
and throughout the stress test, participants’ heart rate was continuously recorded using a 3-lead 
ECG. The stress test was the Trier Social Stress Test (TSST), which includes speech preparation 
(task 1) and presentation (task 2) for 10 minutes followed by completing math problems orally in 
front of an evaluator and video camera for five minutes (task 3) [14]. 
2.1 STATISTICAL ANALYSIS 
In the basic linear regression model, there is an assumption that the random errors are independent. 
This assumption is violated when repeated measures are taken over time from an individual. We 
would expect measurements taken from the same individual to be correlated. That is, 
measurements from the same person will be more similar to each other than measurements from 
different individuals. Mixed effects models allow us to specify a pattern for the correlation of 
measurements taken from the same subject over time. This technique provides more accurate 
estimates than we would get if we were to use simple linear regression. The mixed model allows 
estimation of group differences at each time point while taking the within-subject correlation into 
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account. It also makes it possible for us to assess whether there is a difference in the way in which 
HRV measurements change over time between the two groups. 
The pattern that we specified for the correlation between an individual’s measurements is 
compound symmetry. In compound symmetry, the correlation is the same value for any two 
repeated measurements taken from a given individual. The model specifications are demonstrated 
as follows: 
𝑦𝑦𝜋𝜋𝑗𝑗𝑖𝑖 = 𝛼𝛼𝑗𝑗 + 𝛽𝛽𝑖𝑖 + 𝛾𝛾𝑗𝑗𝑖𝑖 + 𝜃𝜃1 ∙ 𝑥𝑥1𝜋𝜋 + ⋯+ 𝜃𝜃𝑝𝑝 ∙ 𝑥𝑥𝑝𝑝𝜋𝜋 + 𝜖𝜖𝜋𝜋𝑗𝑗𝑖𝑖 
where 𝑦𝑦𝜋𝜋𝑗𝑗𝑖𝑖 is the HRV outcome value for subject i of group j (FH- or FH+) at stage k of the stress 
test and 𝜖𝜖𝜋𝜋𝑗𝑗𝑖𝑖 is the random error associated with this observation. We let j = 0 represent the FH- 
group and j = 1 represent the FH+ group. Since there were five stages of the stress test let k = 0, 1, 
2, 3, 4 where k = 0 represents baseline and k=4 represents the recovery stage. The group effect for 
group j is denoted by 𝛼𝛼𝑗𝑗, the time (stage of stress test) effect for stage k is denoted by 𝛽𝛽𝑖𝑖 and their 
interaction effect is 𝛾𝛾𝑗𝑗𝑖𝑖. The p covariates are 𝑥𝑥1, … , 𝑥𝑥𝑝𝑝 with corresponding coefficients 
𝜃𝜃1, … ,𝜃𝜃𝑝𝑝. We assume the random errors are normally distributed, 𝜖𝜖𝜋𝜋𝑗𝑗𝑖𝑖~𝑁𝑁(0,𝑅𝑅𝜋𝜋), where 𝑅𝑅𝜋𝜋 is the 
covariance matrix of residuals for individual i. We also assume that 𝑅𝑅𝜋𝜋 has compound symmetry, 
that is, for a given individual i,  
 
𝑅𝑅𝜋𝜋 =
⎝
⎜⎜
⎛
𝜎𝜎2 𝜌𝜌𝜎𝜎2 𝜌𝜌𝜎𝜎2 𝜌𝜌𝜎𝜎2 𝜌𝜌𝜎𝜎2
𝜌𝜌𝜎𝜎2 𝜎𝜎2 𝜌𝜌𝜎𝜎2 𝜌𝜌𝜎𝜎2 𝜌𝜌𝜎𝜎2
𝜌𝜌𝜎𝜎2 𝜌𝜌𝜎𝜎2 𝜎𝜎2 𝜌𝜌𝜎𝜎2 𝜌𝜌𝜎𝜎2
𝜌𝜌𝜎𝜎2 𝜌𝜌𝜎𝜎2 𝜌𝜌𝜎𝜎2 𝜎𝜎2 𝜌𝜌𝜎𝜎2
𝜌𝜌𝜎𝜎2 𝜌𝜌𝜎𝜎2 𝜌𝜌𝜎𝜎2 𝜌𝜌𝜎𝜎2 𝜎𝜎2 ⎠
⎟⎟
⎞
 
 
where 𝜎𝜎2 is the variance for each time point and 𝜌𝜌𝜎𝜎2 is the covariance between two time points. 
Here the covariances are all equal to some unspecified multiple, 𝜌𝜌, of the variance.  
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The model simplifies the construction of linear contrasts. As an example, consider the mean 
difference between FH+ and FH- at stage k of the stress test. This can be represented by the model 
as (𝛼𝛼1 − 𝛼𝛼0) + (𝛾𝛾1𝑖𝑖 − 𝛾𝛾0𝑖𝑖) . 
The change from baseline to stage k for the FH- group is given by (𝛽𝛽𝑖𝑖 − 𝛽𝛽0) + (𝛾𝛾0𝑖𝑖 − 𝛾𝛾00) . 
The difference in the change from baseline to stage k between FH+ and FH- is given by  (𝛾𝛾1𝑖𝑖 − 𝛾𝛾10) − (𝛾𝛾0𝑖𝑖 − 𝛾𝛾00) . 
We used SAS to fit this repeated measures mixed effects ANCOVA model for the data for 
nine HRV derived outcomes. The time domain HRV outcome measures were SDNN, SDSD, 
RMSSD, NN50, pNN50, and SDANN. The frequency domain measures were fftHF, fftHFnu, and 
fftLFoverHF.  
One of the assumptions of the ANCOVA model is a normal outcome. Each of the nine 
HRV measures were mathematically transformed so that a histogram of their values followed an 
approximately normal curve. The SDNN, SDSD, RMSSD, SDANN, fftHF measurements were 
transformed by taking the natural log of their values plus one. One was added before taking the 
log because if there were any zeros then taking the log of zero would become an infinite value. 
The log transformation was used because these outcomes were right-skewed. The NN50 and 
pNN50 measures were transformed by taking the square root of their value added to 0.5. This 
transformation was used since these measures are based on counts occurring in a fixed interval. 
Finally, the fftLFoverHF measure was log transformed.  
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3.0  RESULTS 
3.1 DESCRIPTIVE STATISTICS 
All women in the study were healthy (via self-report, physical exam, and blood screening) and 
premenopausal. The mean age of women in the study was 33.5 years, the majority were white 
(76%), well educated (87%), unmarried (52%), and did not have children (65%). The 222 women 
in the study were divided into two groups. The first group of women reported no family history of 
breast cancer in a first degree relative (FH-, n=140). The second group of women reported that a 
first degree relative had breast cancer in the past (FH+, n=82). The women in the FH- group were 
shown to be significantly older than those in the FH+ group via a t-test (FH- 34.3 years ±7.9; FH+ 
32.1 years ±7.0; p=0.04). T-tests revealed that there was no significant difference between the 
groups in BMI or baseline anxiety score (POMS). This measure was included in the mixed model 
as a covariate to account for any differences among subjects in their baseline level of anxiety. A 
chi squared test showed that race differed significantly between groups with FH- being composed 
of 71% white women and FH+ being 83% white women (p=0.05). Education level, marriage 
status, and whether or not they had children did not differ significantly between the two groups. 
Age and BMI have been shown to be significantly associated with HRV so these covariates were 
included in the mixed model [11]. Race was included in the model as a binary covariate (white or 
other) since it differed significantly between the two groups of interest. The final model included 
age, race, BMI, and baseline anxiety as covariates. A summary of socio-demographics for the two 
groups is presented in Table 1. 
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Table 1. Demographics 
Characteristic Total 
(n=222) 
FH+ 
(n=82) 
FH- 
(n=140) 
P-value 
Age(years), mean ± SD 33.49±7.63 32.15±7.02 34.27±7.88 0.04 
BMI(kg/m2), mean ± SD 26.09±5.50 25.90±5.66 26.19±5.42 0.70 
Baseline Anxiety(POMS), mean ± SD 1.95±2.22 2.04±2.28 1.89±2.19 0.64 
Race(white), n(%) 168(75.68) 68(82.93) 100(71.43) 0.05 
Married, n(%) 114(51.58) 45(54.88) 69(49.64) 0.45 
College graduate, n(%) 194(87.39) 72(87.80) 122(87.14) 0.89 
Has children, n(%) 77(34.85) 23(28.05) 54(38.85) 0.10 
 
3.2 MIXED MODEL RESULTS 
All of the HRV measures showed significant changes from baseline to each of the tasks in the 
TSST for both the FH- and FH+ group. The coefficients for the task effect was significant for each 
of the outcomes. Only one of the HRV measures, high frequency power (fftHF), showed 
significant group differences. The p-value associated with the interaction effect between group and 
stage of the stress test was <0.01. Table 2 shows the p-values associated with the three main effects 
for each of the HRV outcomes. Covariates were included in each of the models but their p-values 
are not shown. As discussed previously, each of the outcomes was transformed so that a histogram 
of its values appeared approximately normal. 
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Table 2. P-values for main effects 
Group (FH+ or FH-) Time (stage of test) Interaction 
SDNN 0.69 <0.01 0.87 
SDSD 0.58 <0.01 0.93 
RMSSD 0.58 <0.01 0.93 
NN50 0.05 <0.01 0.70 
pNN50 0.09 <0.01 0.51 
SDANN 0.98 <0.01 0.90 
fftHF 0.20 <0.01 <0.01 
fftHFnu 0.34 <0.01 0.57 
fftLFoverHF 0.22 <0.01 0.33 
*P-values from type 3 test for fixed effects
As previously discussed, fftHF and fftLFoverHF provide indirect measures of parasympathetic 
and sympathetic nervous system activity. To provide a complete picture of autonomic activity 
during the stress test, we investigated results for both fftHF and fftLFoverHF. Tables 3 and 4 give 
estimates for the model coefficients for these two outcomes. Age was the only significant covariate 
for both outcomes. Each task of the stress test was a significant predictor of the fftLF outcome. All 
of the tasks except task 1 were significant predictors of the fftLFoverHF outcome. For the fftHF 
outcome, the group by time interaction was significant for the second and third tasks. None of the 
interactions were significant for the fftLFoverHF outcome. 
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Table 3. Results of ln(fftHF) model 
 Unadjusted Adjusted 
 Coefficient Standard 
Error 
P-value Coefficient Standard 
Error 
P-value 
Intercept 6.95 0.11 <0.01 8.92 0.40 <0.01 
FH- -0.15 0.14 0.29 -0.06 0.14 0.64 
Baseline -0.76 0.05 <0.01 -0.77 0.05 <0.01 
Task 1 -1.04 0.08 <0.01 -1.04 0.08 <0.01 
Task 2 -1.10 0.08 <0.01 -1.11 0.09 <0.01 
Task 3 -1.05 0.08 <0.01 -1.04 0.08 <0.01 
FH-*baseline 0.02 0.06 0.69 0.05 0.06 0.46 
FH-*task 1 -0.09 0.10 0.38 -0.09 0.10 0.37 
FH-*task 2 -0.28 0.10 0.01 -0.27 0.10 0.01 
FH-*task 3 -0.20 0.10 0.04 -0.21 0.10 0.03 
Age    -0.05 0.01 <0.01 
White    0.01 0.15 0.95 
BMI    -0.02 0.01 0.17 
Anxiety    0.03 0.03 0.32 
*FH+ and Recovery were reference groups 
 
Table 4. Results of ln(fftLFoverHF) model 
 Unadjusted Adjusted 
 Coefficient Standard 
Error 
P-value Coefficient Standard 
Error 
P-value 
Intercept 0.59 0.08 <0.01 0.13 0.26 0.63 
FH- -0.19 0.10 0.06 -0.19 0.10 0.06 
Baseline -0.46 0.05 <0.01 -0.46 0.05 <0.01 
Task 1 0.00 0.08 1.00 -0.01 0.08 0.91 
Task 2 0.39 0.08 <0.01 0.39 0.08 <0.01 
Task 3 0.26 0.08 <0.01 0.25 0.08 <0.01 
FH-*baseline 0.12 0.06 0.05 0.12 0.07 0.06 
FH-*task 1 0.00 0.10 0.98 0.01 0.11 0.95 
FH-*task 2 0.13 0.10 0.20 0.13 0.11 0.21 
FH-*task 3 0.10 0.10 0.33 0.12 0.11 0.28 
Age    0.01 0.01 0.02 
White    -0.13 0.10 0.18 
BMI    0.00 0.01 0.93 
Anxiety    0.01 0.02 0.59 
*FH+ and Recovery were reference groups 
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For both groups, fftHF was significantly lower at each of the tasks than it was at baseline. This is 
expected, because parasympathetic activity decreases during stress. For both groups, fftHF was 
significantly higher at recovery than at baseline. At baseline, the first task (speech preparation), 
and at recovery there was no significant difference in fftHF between the two groups. During the 
second task (presentation), the FH+ group had a significantly higher fftHF. The FH- group had a 
significantly larger decrease from baseline to tasks 2 and 3. The FH- group had a significantly 
larger increase in fftHF from both tasks 2 and 3 to recovery. A summary of these group differences 
can be seen in Table 5 and a graph of the changes in fftHF throughout the stress test for both groups 
can be seen in Figure 2 and Figure 3. 
 
 
Table 5. Group differences (FH+ vs FH-) in ln(fftHF) 
Contrast Estimate Standard Error P-value 
Baseline 0.02 0.13 0.89 
Task 1 0.15 0.14 0.32 
Task 2 0.33 0.16 0.03 
Task 3 0.28 0.16 0.08 
Recovery 0.06 0.14 0.64 
Task 1 – baseline 0.14 0.09 0.15 
Task 2 – baseline 0.31 0.09 <0.01 
Task 3 – baseline 0.26 0.09 0.01 
Recovery – baseline 0.05 0.06 0.46 
Task 2 – task 1 0.18 0.12 0.14 
Task 3 – task 1 0.12 0.12 0.32 
Recovery – task 1 -0.09 0.10 0.37 
Task 3 – task 2 -0.06 0.12 0.64 
Recovery – task 2 -0.27 0.10 0.01 
Recovery – task 3 -0.21 0.10 0.03 
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Figure 2. Mixed model estimates of ln(fftHF) over stages of stress test 
 
 
Figure 3. Mixed model estimates of ln(fftHF) over stages of stress test with standard error bars 
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The ratio of low frequency to high frequency (fftLFoverHF) measures sympathetic 
modulation. For both groups, fftLFoverHF was significantly higher at each of the tasks than it was 
at baseline. For both groups, fftLFoverHF was significantly higher at recovery than at baseline. 
There was no significant difference in fftLFoverHF between groups during baseline, each of the 
tasks, and recovery. There was also no significant difference in the changes in fftLFoverHF from 
baseline to each of the tasks and to recovery between the two groups. A summary of these group 
differences can be seen in Table 6 and graph of the changes in fftLFoverHF throughout the stress 
test for both groups is shown in Figure 4 and Figure 5.  
 
 
Table 6. Group differences (FH+ vs FH-) in ln(fftLFoverHF) 
Contrast Estimate Standard Error P-value 
Baseline 0.06 0.09 0.49 
Task 1 0.18 0.12 0.15 
Task 2 0.05 0.12 0.67 
Task 3 0.07 0.12 0.58 
Recovery 0.19 0.10 0.06 
Task 1 – baseline 0.12 0.10 0.24 
Task 2 – baseline -0.01 0.10 0.92 
Task 3 – baseline 0.01 0.10 0.94 
Recovery – baseline 0.12 0.07 0.06 
Task 2 – task 1 -0.13 0.13 0.33 
Task 3 – task 1 -0.11 0.13 0.40 
Recovery – task 1 0.01 0.11 0.95 
Task 3 – task 2 0.02 0.13 0.90 
Recovery – task 2 0.13 0.11 0.21 
Recovery – task 3 0.12 0.11 0.28 
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Figure 4. Mixed model estimates of ln(fftLFoverHF) over stages 
 
 
Figure 5. Mixed model estimates of ln(fftLFoverHF) over stages of stress test with standard error 
bars 
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Figures 2 and 3 show that the fftHF values graphed over the stages of the stress test result 
in a concave up parabola. From Figure 2 we can see that the curve for the FH+ groups has higher 
values of fftHF than the curve for the FH- group. The difference between the points on the curve 
becomes significant only for the second task. The negative slope of the FH- curve is significantly 
steeper from baseline to tasks 2 and 3 and its positive slope is also significantly steeper from tasks 
2 and 3 to the recovery stage. 
Figures 4 and 5 show that the fftLFoverHF values graphed over stages of the stress test 
result in a concave down parabola. While the differences between the curves is not significant, the 
graph shows that the FH+ curve has consistently higher values of fftLFoverHF.  
For mixed models we assume that the residuals are normally distributed about zero and 
uncorrelated (that is, residuals from different subjects are not correlated). This assumption was 
checked and it was found that the residuals were normally distributed about zero for both the fftHF 
and fftLFoverHF outcomes. This can be seen in the plots shown in Figures 6 and 7. The residuals 
appear to be evenly distributed about zero and do not show a pattern or heteroscedasticity. The 
histograms of the residuals look like fairly close approximations of normal curves. The QQ-plots 
show that the residuals closely approximate a normal distribution. 
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Figure 6. Residual diagnostics for ln(fftHF) 
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Figure 7. Residual diagnostics for ln(LFoverHF) 
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4.0  DISCUSSION 
The plots of the fftHF and fftLFoverHF outcomes over time in Figures 2 through 5 coincide with 
the current understanding of the activity of the sympathetic and parasympathetic system. In 
response to stress we would expect fight or flight (sympathetic activity) to “kick in”. In order to 
conserve energy, the activity of the parasympathetic nervous system decreases as the sympathetic 
activity increases. This can be seen in the aforementioned figures since the fftHF values, which 
measures parasympathetic activity, decrease from baseline to the speech and verbal math activities 
and then increase when the tasks are over. The values of fftHF during the recovery period are 
higher than those at baseline. The recovery stage may be a better approximation of baseline levels 
since subjects may have been nervous about the test before it started. This is a possible explanation 
for the differences in values of fftHF between baseline and recovery for both groups.  
The fftLFoverHF values, a measure of sympathetic activity, increased from baseline to the 
two tasks then decrease to recovery. This spike in activity was likely caused by the subject’s stress 
response to the TSST. The TSST has been shown to affect the stress levels of subjects in multiple 
other studies. For example, two different studies showed the heightened physiological response 
and endocrine response during the TSST for women with a family history of breast cancer [7], [8]. 
The mirroring of the stress exposure by the HRV measures, fftHF and fftLFoverHF, show that 
they are good proxies for sympathetic and parasympathetic activity.  
Figures 2 and 4 both show that the estimates for women with a family history of breast 
cancer were above the estimates of those without a family history of breast cancer. This could 
mean that these women have an elevated level of activity in the two branches of their nervous 
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system. This result would agree with the findings of previous studies that showed that women with 
a family history of breast cancer reacted more severely to stress tests [7], [8]. 
Because there is minimal missing data and the results found in this study agree with 
previous findings, it is likely that we are observing a real difference in stress reactivity among 
women with and without a family history of breast cancer. This finding is a demonstration of one 
of the effects of a family history of breast cancer on women’s physiology. Future work may seek 
to find other ways these women are different physically and psychologically. 
4.1 LIMITATIONS 
The study sample was relatively small and the participants were mostly young, very well educated 
and mainly white. This limits the generalizability of the results. Also, participants volunteered to 
be in the study and the flyers were placed around a university campus so this was not a true random 
sample of women living in the area.  
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APPENDIX: SAS CODE 
dm 'log;clear;output;clear'; 
options nodate ls=113 ps=63 pageno=1; 
footnote1 'End of Page'; 
 
libname v1 "\\Mac\Home\Desktop\Thesis"; 
options nofmterr; 
 
data wsrs; 
set v1.wsrs; 
where haveEADSd=1; *only want people who completed the stress test; 
run; 
 
data wsrs_long; *transform data wide to long; 
set wsrs; 
 
time=1; 
SDNN=SDNNs1; 
SDSD=SDSDs1; 
RMSSD=RMSSDs1; 
NN50=NN50s1; 
pNN50=pNN50s1; 
SDANN=SDANNs1; 
fftHF=fftHFs1; 
fftHFnu=fftHFnus1; 
fftLFoverHF=fftLFoverHFs1; 
output; 
 
time=2; 
SDNN=SDNNs2; 
SDSD=SDSDs2; 
RMSSD=RMSSDs2; 
NN50=NN50s2; 
pNN50=pNN50s2; 
SDANN=SDANNs2; 
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fftHF=fftHFs2; 
fftHFnu=fftHFnus2; 
fftLFoverHF=fftLFoverHFs2; 
output; 
 
time=3; 
SDNN=SDNNs3; 
SDSD=SDSDs3; 
RMSSD=RMSSDs3; 
NN50=NN50s3; 
pNN50=pNN50s3; 
SDANN=SDANNs3; 
fftHF=fftHFs3; 
fftHFnu=fftHFnus3; 
fftLFoverHF=fftLFoverHFs3; 
output; 
 
time=4; 
SDNN=SDNNs4; 
SDSD=SDSDs4; 
RMSSD=RMSSDs4; 
NN50=NN50s4; 
pNN50=pNN50s4; 
SDANN=SDANNs4; 
fftHF=fftHFs4; 
fftHFnu=fftHFnus4; 
fftLFoverHF=fftLFoverHFs4; 
output; 
 
time=5; 
SDNN=SDNNs5; 
SDSD=SDSDs5; 
RMSSD=RMSSDs5; 
NN50=NN50s5; 
pNN50=pNN50s5; 
SDANN=SDANNs5; 
fftHF=fftHFs5; 
fftHFnu=fftHFnus5; 
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fftLFoverHF=fftLFoverHFs5; 
output; 
 
time=6; 
SDNN=SDNNs6; 
SDSD=SDSDs6; 
RMSSD=RMSSDs6; 
NN50=NN50s6; 
pNN50=pNN50s6; 
SDANN=SDANNs6; 
fftHF=fftHFs6; 
fftHFnu=fftHFnus6; 
fftLFoverHF=fftLFoverHFs6; 
output; 
 
time=7; 
SDNN=SDNNs7; 
SDSD=SDSDs7; 
RMSSD=RMSSDs7; 
NN50=NN50s7; 
pNN50=pNN50s7; 
SDANN=SDANNs7; 
fftHF=fftHFs7; 
fftHFnu=fftHFnus7; 
fftLFoverHF=fftLFoverHFs7; 
output; 
 
time=8; 
SDNN=SDNNs8; 
SDSD=SDSDs8; 
RMSSD=RMSSDs8; 
NN50=NN50s8; 
pNN50=pNN50s8; 
SDANN=SDANNs8; 
fftHF=fftHFs8; 
fftHFnu=fftHFnus8; 
fftLFoverHF=fftLFoverHFs8; 
output; 
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time=9; 
SDNN=SDNNs9; 
SDSD=SDSDs9; 
RMSSD=RMSSDs9; 
NN50=NN50s9; 
pNN50=pNN50s9; 
SDANN=SDANNs9; 
fftHF=fftHFs9; 
fftHFnu=fftHFnus9; 
fftLFoverHF=fftLFoverHFs9; 
output; 
 
time=10; 
SDNN=SDNNs10; 
SDSD=SDSDs10; 
RMSSD=RMSSDs10; 
NN50=NN50s10; 
pNN50=pNN50s10; 
SDANN=SDANNs10; 
fftHF=fftHFs10; 
fftHFnu=fftHFnus10; 
fftLFoverHF=fftLFoverHFs10; 
output; 
 
time=11; 
SDNN=SDNNs11; 
SDSD=SDSDs11; 
RMSSD=RMSSDs11; 
NN50=NN50s11; 
pNN50=pNN50s11; 
SDANN=SDANNs11; 
fftHF=fftHFs11; 
fftHFnu=fftHFnus11; 
fftLFoverHF=fftLFoverHFs11; 
output; 
 
time=12; 
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SDNN=SDNNs12; 
SDSD=SDSDs12; 
RMSSD=RMSSDs12; 
NN50=NN50s12; 
pNN50=pNN50s12; 
SDANN=SDANNs12; 
fftHF=fftHFs12; 
fftHFnu=fftHFnus12; 
fftLFoverHF=fftLFoverHFs12; 
output; 
 
keep id time age race_bin edu_vin mar_bin kid_bin sheight sweight SBMI 
SBanxietyFHjohn SDNN SDSD RMSSD NN50 pNN50 SDANN fftHF fftHFnu fftLFoverHF; 
run; 
 
data wsrs_long; *transform data to get normalized outcomes; 
set wsrs_long; 
SDNN_t=log(SDNN+1); 
SDSD_t=log(SDSD+1); 
RMSSD_t=log(RMSSD+1); 
NN50_t=sqrt(NN50+0.5); 
pNN50_t=sqrt(pNN50+0.5); 
SDANN_t=log(SDANN+1); 
fftHF_t=log(fftHF+1); 
fftLFoverHF_t=log(fftLFoverHF); 
run; 
 
data combine; *create stages of stress test; 
set wsrs_long; 
stage = 1; 
if time=7 then stage=2; 
if time=8 then stage=3; 
if time=9 then stage=4; 
if time>9 then stage=5; 
run; 
 
 
proc mixed data=combine; *create mixed models for each of 9 HRV outcomes; 
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class FHjohn stage id; *FHjohn is group variable where 1=FH+; 
model SDNN_t=FHjohn stage FHjohn*stage Age race_bin SBMI SBanxiety /solution; 
repeated stage/subject=id type=cs; 
estimate 'mean SDNN for FH- at baseline' intercept 1 FHjohn 1 0 stage 1 
FHjohn*stage 1 0/E; 
estimate 'mean SDNN for FH- at task 1' intercept 1 FHjohn 1 0 stage 0 1 
FHjohn*stage 0 1/E; 
estimate 'mean SDNN for FH- at task 2' intercept 1 FHjohn 1 0 stage 0 0 1 
FHjohn*stage 0 0 1/E; 
estimate 'mean SDNN for FH- at task 3' intercept 1 FHjohn 1 0 stage 0 0 0 1 
FHjohn*stage 0 0 0 1/E; 
estimate 'mean SDNN for FH- at recovery' intercept 1 FHjohn 1 0 stage 0 0 0 0 
1 FHjohn*stage 0 0 0 0 1/E; 
estimate 'mean SDNN for FH+ at baseline' intercept 1 FHjohn 0 1 stage 1 
FHjohn*stage 0 0 0 0 0 1/E; 
estimate 'mean SDNN for FH+ at task 1' intercept 1 FHjohn 0 1 stage 0 1 
FHjohn*stage 0 0 0 0 0 0 1/E; 
estimate 'mean SDNN for FH+ at task 2' intercept 1 FHjohn 0 1 stage 0 0 1 
FHjohn*stage 0 0 0 0 0 0 0 1/E; 
estimate 'mean SDNN for FH+ at task 3' intercept 1 FHjohn 0 1 stage 0 0 0 1 
FHjohn*stage 0 0 0 0 0 0 0 0 1/E; 
estimate 'mean SDNN for FH+ at recovery' intercept 1 FHjohn 0 1 stage 0 0 0 0 
1 FHjohn*stage 0 0 0 0 0 0 0 0 0 1/E; 
estimate 'change from baseline to task 1 for FH-' stage -1 1 0 0 0 
Fhjohn*stage -1 1 0 0 0 0 0 0 0 0/E; 
estimate 'change from baseline to task 2 for FH-' stage -1 0 1 0 0 
Fhjohn*stage -1 0 1 0 0 0 0 0 0 0/E; 
estimate 'change from baseline to task 3 for FH-' stage -1 0 0 1 0 
Fhjohn*stage -1 0 0 1 0 0 0 0 0 0/E; 
estimate 'change from baseline to recovery for FH-' stage -1 0 0 0 1 
Fhjohn*stage -1 0 0 0 1 0 0 0 0 0/E; 
estimate 'change from task 1 to recovery for FH-' stage 0 1 0 0 -1 
FHjohn*stage 0 1 0 0 -1 0 0 0 0 0/E; 
estimate 'change from task 2 to recovery for FH-' stage 0 0 1 0 -1 
FHjohn*stage 0 0 1 0 -1 0 0 0 0 0/E; 
estimate 'change from task 3 to recovery for FH-' stage 0 0 0 1 -1 
FHjohn*stage 0 0 0 1 -1 0 0 0 0 0/E; 
estimate 'change from baseline to task 1 for FH+' stage -1 1 0 0 0 
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Fhjohn*stage 0 0 0 0 0 -1 1 0 0 0/E; 
estimate 'change from baseline to task 2 for FH+' stage -1 0 1 0 0 
Fhjohn*stage 0 0 0 0 0 -1 0 1 0 0/E; 
estimate 'change from baseline to task 3 for FH+' stage -1 0 0 1 0 
Fhjohn*stage 0 0 0 0 0 -1 0 0 1 0/E; 
estimate 'change from baseline to recovery for FH+' stage -1 0 0 0 1 
Fhjohn*stage 0 0 0 0 0 -1 0 0 0 1/E; 
estimate 'change from task 1 to recovery for FH+' stage 0 1 0 0 -1 
FHjohn*stage 0 0 0 0 0 0 1 0 0 -1/E; 
estimate 'change from task 2 to recovery for FH+' stage 0 0 1 0 -1 
FHjohn*stage 0 0 0 0 0 0 0 1 0 -1/E; 
estimate 'change from task 3 to recovery for FH+' stage 0 0 0 1 -1 
FHjohn*stage 0 0 0 0 0 0 0 0 1 -1/E; 
estimate 'diff SDNN for FH+/- at baseline' FHjohn -1 1 FHjohn*stage -1 0 0 0 
0 1 0 0 0 0 /E; 
estimate 'diff SDNN for FH+/- at task 1'   FHjohn -1 1 FHjohn*stage 0 -1 0 0 
0 0 1 0 0 0 /E; 
estimate 'diff SDNN for FH+/- at task 2'   FHjohn -1 1 FHjohn*stage 0 0 -1 0 
0 0 0 1 0 0 /E; 
estimate 'diff SDNN for FH+/- at task 3'   FHjohn -1 1 FHjohn*stage 0 0 0 -1 
0 0 0 0 1 0 /E; 
estimate 'diff SDNN for FH+/- at recovery' FHjohn -1 1 FHjohn*stage 0 0 0 0 -
1 0 0 0 0 1 /E; 
estimate 'diff SDNN change (task 1- baseline) for FH+/-' FHjohn*stage 1 -1 0 
0 0 -1 1 0 0 0 /E; 
estimate 'diff SDNN change (task 2- baseline) for FH+/-' FHjohn*stage 1 0 -1 
0 0 -1 0 1 0 0 /E; 
estimate 'diff SDNN change (task 3- baseline) for FH+/-' FHjohn*stage 1 0 0 -
1 0 -1 0 0 1 0 /E; 
estimate 'diff SDNN change (recovery- baseline) for FH+/-' FHjohn*stage 1 0 0 
0 -1 -1 0 0 0 1 /E; 
estimate 'diff SDNN change (task 2- task 1) for FH+/-' FHjohn*stage 0 1 -1 0 
0 0 -1 1 0 0 /E; 
estimate 'diff SDNN change (task 3- task 1) for FH+/-' FHjohn*stage 0 1 0 -1 
0 0 -1 0 1 0 /E; 
estimate 'diff SDNN change (recovery- task 1) for FH+/-' FHjohn*stage 0 1 0 0 
-1 0 -1 0 0 1 /E; 
estimate 'diff SDNN change (task 3- task 2) for FH+/-' FHjohn*stage 0 0 1 -1 
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0 0 0 -1 1 0/E; 
estimate 'diff SDNN change (recovery- task 2) for FH+/-' FHjohn*stage 0 0 1 0 
-1 0 0 -1 0 1/E; 
estimate 'diff SDNN change (recovery- task 3) for FH+/-' FHjohn*stage 0 0 0 1 
-1 0 0 0 -1 1/E; 
run; 
 
proc mixed data=combine; 
class FHjohn stage id ; 
model SDSD_t=FHjohn stage FHjohn*stage Age race_bin SBMI SBanxiety /solution; 
repeated stage/subject=id type=cs; 
estimate 'mean SDSD for FH- at baseline' intercept 1 FHjohn 1 0 stage 1 
FHjohn*stage 1 0/E; 
estimate 'mean SDSD for FH- at task 1' intercept 1 FHjohn 1 0 stage 0 1 
FHjohn*stage 0 1/E; 
estimate 'mean SDSD for FH- at task 2' intercept 1 FHjohn 1 0 stage 0 0 1 
FHjohn*stage 0 0 1/E; 
estimate 'mean SDSD for FH- at task 3' intercept 1 FHjohn 1 0 stage 0 0 0 1 
FHjohn*stage 0 0 0 1/E; 
estimate 'mean SDSD for FH- at recovery' intercept 1 FHjohn 1 0 stage 0 0 0 0 
1 FHjohn*stage 0 0 0 0 1/E; 
estimate 'mean SDSD for FH+ at baseline' intercept 1 FHjohn 0 1 stage 1 
FHjohn*stage 0 0 0 0 0 1/E; 
estimate 'mean SDSD for FH+ at task 1' intercept 1 FHjohn 0 1 stage 0 1 
FHjohn*stage 0 0 0 0 0 0 1/E; 
estimate 'mean SDSD for FH+ at task 2' intercept 1 FHjohn 0 1 stage 0 0 1 
FHjohn*stage 0 0 0 0 0 0 0 1/E; 
estimate 'mean SDSD for FH+ at task 3' intercept 1 FHjohn 0 1 stage 0 0 0 1 
FHjohn*stage 0 0 0 0 0 0 0 0 1/E; 
estimate 'mean SDSD for FH+ at recovery' intercept 1 FHjohn 0 1 stage 0 0 0 0 
1 FHjohn*stage 0 0 0 0 0 0 0 0 0 1/E; 
estimate 'change from baseline to task 1 for FH-' stage -1 1 0 0 0 
Fhjohn*stage -1 1 0 0 0 0 0 0 0 0/E; 
estimate 'change from baseline to task 2 for FH-' stage -1 0 1 0 0 
Fhjohn*stage -1 0 1 0 0 0 0 0 0 0/E; 
estimate 'change from baseline to task 3 for FH-' stage -1 0 0 1 0 
Fhjohn*stage -1 0 0 1 0 0 0 0 0 0/E; 
estimate 'change from baseline to recovery for FH-' stage -1 0 0 0 1 
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Fhjohn*stage -1 0 0 0 1 0 0 0 0 0/E; 
estimate 'change from task 1 to recovery for FH-' stage 0 1 0 0 -1 
FHjohn*stage 0 1 0 0 -1 0 0 0 0 0/E; 
estimate 'change from task 2 to recovery for FH-' stage 0 0 1 0 -1 
FHjohn*stage 0 0 1 0 -1 0 0 0 0 0/E; 
estimate 'change from task 3 to recovery for FH-' stage 0 0 0 1 -1 
FHjohn*stage 0 0 0 1 -1 0 0 0 0 0/E; 
estimate 'change from baseline to task 1 for FH+' stage -1 1 0 0 0 
Fhjohn*stage 0 0 0 0 0 -1 1 0 0 0/E; 
estimate 'change from baseline to task 2 for FH+' stage -1 0 1 0 0 
Fhjohn*stage 0 0 0 0 0 -1 0 1 0 0/E; 
estimate 'change from baseline to task 3 for FH+' stage -1 0 0 1 0 
Fhjohn*stage 0 0 0 0 0 -1 0 0 1 0/E; 
estimate 'change from baseline to recovery for FH+' stage -1 0 0 0 1 
Fhjohn*stage 0 0 0 0 0 -1 0 0 0 1/E; 
estimate 'change from task 1 to recovery for FH+' stage 0 1 0 0 -1 
FHjohn*stage 0 0 0 0 0 0 1 0 0 -1/E; 
estimate 'change from task 2 to recovery for FH+' stage 0 0 1 0 -1 
FHjohn*stage 0 0 0 0 0 0 0 1 0 -1/E; 
estimate 'change from task 3 to recovery for FH+' stage 0 0 0 1 -1 
FHjohn*stage 0 0 0 0 0 0 0 0 1 -1/E; 
estimate 'diff SDSD for FH+/- at baseline' FHjohn -1 1 FHjohn*stage -1 0 0 0 
0 1 0 0 0 0 /E; 
estimate 'diff SDSD for FH+/- at task 1' FHjohn -1 1 FHjohn*stage 0 -1 0 0 0 
0 1 0 0 0 /E; 
estimate 'diff SDSD for FH+/- at task 2' FHjohn -1 1 FHjohn*stage 0 0 -1 0 0 
0 0 1 0 0 /E; 
estimate 'diff SDSD for FH+/- at task 3' FHjohn -1 1 FHjohn*stage 0 0 0 -1 0 
0 0 0 1 0 /E; 
estimate 'diff SDSD for FH+/- at recovery' FHjohn -1 1 FHjohn*stage 0 0 0 0 -
1 0 0 0 0 1 /E; 
estimate 'diff SDSD change (task 1- baseline) for FH+/-' FHjohn*stage 1 -1 0 
0 0 -1 1 0 0 0 /E; 
estimate 'diff SDSD change (task 2- baseline) for FH+/-' FHjohn*stage 1 0 -1 
0 0 -1 0 1 0 0 /E; 
estimate 'diff SDSD change (task 3- baseline) for FH+/-' FHjohn*stage 1 0 0 -
1 0 -1 0 0 1 0 /E; 
estimate 'diff SDSD change (recovery- baseline) for FH+/-' FHjohn*stage 1 0 0 
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0 -1 -1 0 0 0 1 /E; 
estimate 'diff SDSD change (task 2- task 1) for FH+/-' FHjohn*stage 0 1 -1 0 
0 0 -1 1 0 0 /E; 
estimate 'diff SDSD change (task 3- task 1) for FH+/-' FHjohn*stage 0 1 0 -1 
0 0 -1 0 1 0 /E; 
estimate 'diff SDSD change (recovery- task 1) for FH+/-' FHjohn*stage 0 1 0 0 
-1 0 -1 0 0 1 /E; 
estimate 'diff SDSD change (task 3- task 2) for FH+/-' FHjohn*stage 0 0 1 -1 
0 0 0 -1 1 0/E; 
estimate 'diff SDSD change (recovery- task 2) for FH+/-' FHjohn*stage 0 0 1 0 
-1 0 0 -1 0 1/E; 
estimate 'diff SDSD change (recovery- task 3) for FH+/-' FHjohn*stage 0 0 0 1 
-1 0 0 0 -1 1/E; 
run; 
 
proc mixed data=combine; 
class FHjohn stage id time; 
model RMSSD_t=FHjohn stage FHjohn*stage Age race_bin SBMI SBanxiety/solution; 
repeated stage/subject=id type=cs; 
estimate 'mean RMSSD for FH- at baseline' intercept 1 FHjohn 1 0 stage 1 
FHjohn*stage 1 0/E; 
estimate 'mean RMSSD for FH- at task 1' intercept 1 FHjohn 1 0 stage 0 1 
FHjohn*stage 0 1/E; 
estimate 'mean RMSSD for FH- at task 2' intercept 1 FHjohn 1 0 stage 0 0 1 
FHjohn*stage 0 0 1/E; 
estimate 'mean RMSSD for FH- at task 3' intercept 1 FHjohn 1 0 stage 0 0 0 1 
FHjohn*stage 0 0 0 1/E; 
estimate 'mean RMSSD for FH- at recovery' intercept 1 FHjohn 1 0 stage 0 0 0 
0 1 FHjohn*stage 0 0 0 0 1/E; 
estimate 'mean RMSSD for FH+ at baseline' intercept 1 FHjohn 0 1 stage 1 
FHjohn*stage 0 0 0 0 0 1/E; 
estimate 'mean RMSSD for FH+ at task 1' intercept 1 FHjohn 0 1 stage 0 1 
FHjohn*stage 0 0 0 0 0 0 1/E; 
estimate 'mean RMSSD for FH+ at task 2' intercept 1 FHjohn 0 1 stage 0 0 1 
FHjohn*stage 0 0 0 0 0 0 0 1/E; 
estimate 'mean RMSSD for FH+ at task 3' intercept 1 FHjohn 0 1 stage 0 0 0 1 
FHjohn*stage 0 0 0 0 0 0 0 0 1/E; 
estimate 'mean RMSSD for FH+ at recovery' intercept 1 FHjohn 0 1 stage 0 0 0 
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0 1 FHjohn*stage 0 0 0 0 0 0 0 0 0 1/E; 
estimate 'change from baseline to task 1 for FH-' stage -1 1 0 0 0 
Fhjohn*stage -1 1 0 0 0 0 0 0 0 0/E; 
estimate 'change from baseline to task 2 for FH-' stage -1 0 1 0 0 
Fhjohn*stage -1 0 1 0 0 0 0 0 0 0/E; 
estimate 'change from baseline to task 3 for FH-' stage -1 0 0 1 0 
Fhjohn*stage -1 0 0 1 0 0 0 0 0 0/E; 
estimate 'change from baseline to recovery for FH-' stage -1 0 0 0 1 
Fhjohn*stage -1 0 0 0 1 0 0 0 0 0/E; 
estimate 'change from task 1 to recovery for FH-' stage 0 1 0 0 -1 
FHjohn*stage 0 1 0 0 -1 0 0 0 0 0/E; 
estimate 'change from task 2 to recovery for FH-' stage 0 0 1 0 -1 
FHjohn*stage 0 0 1 0 -1 0 0 0 0 0/E; 
estimate 'change from task 3 to recovery for FH-' stage 0 0 0 1 -1 
FHjohn*stage 0 0 0 1 -1 0 0 0 0 0/E; 
estimate 'change from baseline to task 1 for FH+' stage -1 1 0 0 0 
Fhjohn*stage 0 0 0 0 0 -1 1 0 0 0/E; 
estimate 'change from baseline to task 2 for FH+' stage -1 0 1 0 0 
Fhjohn*stage 0 0 0 0 0 -1 0 1 0 0/E; 
estimate 'change from baseline to task 3 for FH+' stage -1 0 0 1 0 
Fhjohn*stage 0 0 0 0 0 -1 0 0 1 0/E; 
estimate 'change from baseline to recovery for FH+' stage -1 0 0 0 1 
Fhjohn*stage 0 0 0 0 0 -1 0 0 0 1/E; 
estimate 'change from task 1 to recovery for FH+' stage 0 1 0 0 -1 
FHjohn*stage 0 0 0 0 0 0 1 0 0 -1/E; 
estimate 'change from task 2 to recovery for FH+' stage 0 0 1 0 -1 
FHjohn*stage 0 0 0 0 0 0 0 1 0 -1/E; 
estimate 'change from task 3 to recovery for FH+' stage 0 0 0 1 -1 
FHjohn*stage 0 0 0 0 0 0 0 0 1 -1/E; 
estimate 'diff RMSSD for FH+/- at baseline' FHjohn -1 1 FHjohn*stage -1 0 0 0 
0 1 0 0 0 0 /E; 
estimate 'diff RMSSD for FH+/- at task 1' FHjohn -1 1 FHjohn*stage 0 -1 0 0 0 
0 1 0 0 0 /E; 
estimate 'diff RMSSD for FH+/- at task 2' FHjohn -1 1 FHjohn*stage 0 0 -1 0 0 
0 0 1 0 0 /E; 
estimate 'diff RMSSD for FH+/- at task 3' FHjohn -1 1 FHjohn*stage 0 0 0 -1 0 
0 0 0 1 0 /E; 
estimate 'diff RMSSD for FH+/- at recovery' FHjohn -1 1 FHjohn*stage 0 0 0 0 
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-1 0 0 0 0 1 /E; 
estimate 'diff RMSSD change (task 1- baseline) for FH+/-' FHjohn*stage 1 -1 0 
0 0 -1 1 0 0 0 /E; 
estimate 'diff RMSSD change (task 2- baseline) for FH+/-' FHjohn*stage 1 0 -1 
0 0 -1 0 1 0 0 /E; 
estimate 'diff RMSSD change (task 3- baseline) for FH+/-' FHjohn*stage 1 0 0 
-1 0 -1 0 0 1 0 /E; 
estimate 'diff RMSSD change (recovery- baseline) for FH+/-' FHjohn*stage 1 0 
0 0 -1 -1 0 0 0 1 /E; 
estimate 'diff RMSSD change (task 2- task 1) for FH+/-' FHjohn*stage 0 1 -1 0 
0 0 -1 1 0 0 /E; 
estimate 'diff RMSSD change (task 3- task 1) for FH+/-' FHjohn*stage 0 1 0 -1 
0 0 -1 0 1 0 /E; 
estimate 'diff RMSSD change (recovery- task 1) for FH+/-' FHjohn*stage 0 1 0 
0 -1 0 -1 0 0 1 /E; 
estimate 'diff RMSSD change (task 3- task 2) for FH+/-' FHjohn*stage 0 0 1 -1 
0 0 0 -1 1 0/E; 
estimate 'diff RMSSD change (recovery- task 2) for FH+/-' FHjohn*stage 0 0 1 
0 -1 0 0 -1 0 1/E; 
estimate 'diff RMSSD change (recovery- task 3) for FH+/-' FHjohn*stage 0 0 0 
1 -1 0 0 0 -1 1/E; 
run; 
 
proc mixed data=combine; 
class FHjohn stage id time; 
model NN50_t=FHjohn stage FHjohn*stage Age race_bin SBMI SBanxiety/solution; 
repeated stage/subject=id type=cs; 
estimate 'mean NN50 for FH- at baseline' intercept 1 FHjohn 1 0 stage 1 
FHjohn*stage 1 0/E; 
estimate 'mean NN50 for FH- at task 1'   intercept 1 FHjohn 1 0 stage 0 1 
FHjohn*stage 0 1/E; 
estimate 'mean NN50 for FH- at task 2'   intercept 1 FHjohn 1 0 stage 0 0 1 
FHjohn*stage 0 0 1/E; 
estimate 'mean NN50 for FH- at task 3'   intercept 1 FHjohn 1 0 stage 0 0 0 1 
FHjohn*stage 0 0 0 1/E; 
estimate 'mean NN50 for FH- at recovery' intercept 1 FHjohn 1 0 stage 0 0 0 0 
1 FHjohn*stage 0 0 0 0 1/E; 
estimate 'mean NN50 for FH+ at baseline' intercept 1 FHjohn 0 1 stage 1 
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FHjohn*stage 0 0 0 0 0 1/E; 
estimate 'mean NN50 for FH+ at task 1'   intercept 1 FHjohn 0 1 stage 0 1 
FHjohn*stage 0 0 0 0 0 0 1/E; 
estimate 'mean NN50 for FH+ at task 2'   intercept 1 FHjohn 0 1 stage 0 0 1 
FHjohn*stage 0 0 0 0 0 0 0 1/E; 
estimate 'mean NN50 for FH+ at task 3'   intercept 1 FHjohn 0 1 stage 0 0 0 1 
FHjohn*stage 0 0 0 0 0 0 0 0 1/E; 
estimate 'mean NN50 for FH+ at recovery' intercept 1 FHjohn 0 1 stage 0 0 0 0 
1 FHjohn*stage 0 0 0 0 0 0 0 0 0 1/E; 
estimate 'change from baseline to task 1 for FH-' stage -1 1 0 0 0 
Fhjohn*stage -1 1 0 0 0 0 0 0 0 0/E; 
estimate 'change from baseline to task 2 for FH-' stage -1 0 1 0 0 
Fhjohn*stage -1 0 1 0 0 0 0 0 0 0/E; 
estimate 'change from baseline to task 3 for FH-' stage -1 0 0 1 0 
Fhjohn*stage -1 0 0 1 0 0 0 0 0 0/E; 
estimate 'change from baseline to recovery for FH-' stage -1 0 0 0 1 
Fhjohn*stage -1 0 0 0 1 0 0 0 0 0/E; 
estimate 'change from task 1 to recovery for FH-' stage 0 1 0 0 -1 
FHjohn*stage 0 1 0 0 -1 0 0 0 0 0/E; 
estimate 'change from task 2 to recovery for FH-' stage 0 0 1 0 -1 
FHjohn*stage 0 0 1 0 -1 0 0 0 0 0/E; 
estimate 'change from task 3 to recovery for FH-' stage 0 0 0 1 -1 
FHjohn*stage 0 0 0 1 -1 0 0 0 0 0/E; 
estimate 'change from baseline to task 1 for FH+' stage -1 1 0 0 0 
Fhjohn*stage 0 0 0 0 0 -1 1 0 0 0/E; 
estimate 'change from baseline to task 2 for FH+' stage -1 0 1 0 0 
Fhjohn*stage 0 0 0 0 0 -1 0 1 0 0/E; 
estimate 'change from baseline to task 3 for FH+' stage -1 0 0 1 0 
Fhjohn*stage 0 0 0 0 0 -1 0 0 1 0/E; 
estimate 'change from baseline to recovery for FH+' stage -1 0 0 0 1 
Fhjohn*stage 0 0 0 0 0 -1 0 0 0 1/E; 
estimate 'change from task 1 to recovery for FH+' stage 0 1 0 0 -1 
FHjohn*stage 0 0 0 0 0 0 1 0 0 -1/E; 
estimate 'change from task 2 to recovery for FH+' stage 0 0 1 0 -1 
FHjohn*stage 0 0 0 0 0 0 0 1 0 -1/E; 
estimate 'change from task 3 to recovery for FH+' stage 0 0 0 1 -1 
FHjohn*stage 0 0 0 0 0 0 0 0 1 -1/E; 
estimate 'diff NN50 for FH+/- at baseline' FHjohn -1 1 FHjohn*stage -1 0 0 0 
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0 1 0 0 0 0 /E; 
estimate 'diff NN50 for FH+/- at task 1' FHjohn -1 1 FHjohn*stage 0 -1 0 0 0 
0 1 0 0 0 /E; 
estimate 'diff NN50 for FH+/- at task 2' FHjohn -1 1 FHjohn*stage 0 0 -1 0 0 
0 0 1 0 0 /E; 
estimate 'diff NN50 for FH+/- at task 3' FHjohn -1 1 FHjohn*stage 0 0 0 -1 0 
0 0 0 1 0 /E; 
estimate 'diff NN50 for FH+/- at recovery' FHjohn -1 1 FHjohn*stage 0 0 0 0 -
1 0 0 0 0 1 /E; 
estimate 'diff NN50 change (task 1- baseline) for FH+/-' FHjohn*stage 1 -1 0 
0 0 -1 1 0 0 0 /E; 
estimate 'diff NN50 change (task 2- baseline) for FH+/-' FHjohn*stage 1 0 -1 
0 0 -1 0 1 0 0 /E; 
estimate 'diff NN50 change (task 3- baseline) for FH+/-' FHjohn*stage 1 0 0 -
1 0 -1 0 0 1 0 /E; 
estimate 'diff NN50 change (recovery- baseline) for FH+/-' FHjohn*stage 1 0 0 
0 -1 -1 0 0 0 1 /E; 
estimate 'diff NN50 change (task 2- task 1) for FH+/-' FHjohn*stage 0 1 -1 0 
0 0 -1 1 0 0 /E; 
estimate 'diff NN50 change (task 3- task 1) for FH+/-' FHjohn*stage 0 1 0 -1 
0 0 -1 0 1 0 /E; 
estimate 'diff NN50 change (recovery- task 1) for FH+/-' FHjohn*stage 0 1 0 0 
-1 0 -1 0 0 1 /E; 
estimate 'diff NN50 change (task 3- task 2) for FH+/-' FHjohn*stage 0 0 1 -1 
0 0 0 -1 1 0/E; 
estimate 'diff NN50 change (recovery- task 2) for FH+/-' FHjohn*stage 0 0 1 0 
-1 0 0 -1 0 1/E; 
estimate 'diff NN50 change (recovery- task 3) for FH+/-' FHjohn*stage 0 0 0 1 
-1 0 0 0 -1 1/E; 
run; 
 
proc mixed data=combine; 
class FHjohn stage id time; 
model pNN50_t=FHjohn stage FHjohn*stage Age race_bin SBMI SBanxiety/solution; 
repeated stage/subject=id type=cs; 
estimate 'mean pNN50 for FH- at baseline' intercept 1 FHjohn 1 0 stage 1 
FHjohn*stage 1 0/E; 
estimate 'mean pNN50 for FH- at task 1' intercept 1 FHjohn 1 0 stage 0 1 
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FHjohn*stage 0 1/E; 
estimate 'mean pNN50 for FH- at task 2' intercept 1 FHjohn 1 0 stage 0 0 1 
FHjohn*stage 0 0 1/E; 
estimate 'mean pNN50 for FH- at task 3' intercept 1 FHjohn 1 0 stage 0 0 0 1 
FHjohn*stage 0 0 0 1/E; 
estimate 'mean pNN50 for FH- at recovery' intercept 1 FHjohn 1 0 stage 0 0 0 
0 1 FHjohn*stage 0 0 0 0 1/E; 
estimate 'mean pNN50 for FH+ at baseline' intercept 1 FHjohn 0 1 stage 1 
FHjohn*stage 0 0 0 0 0 1/E; 
estimate 'mean pNN50 for FH+ at task 1' intercept 1 FHjohn 0 1 stage 0 1 
FHjohn*stage 0 0 0 0 0 0 1/E; 
estimate 'mean pNN50 for FH+ at task 2' intercept 1 FHjohn 0 1 stage 0 0 1 
FHjohn*stage 0 0 0 0 0 0 0 1/E; 
estimate 'mean pNN50 for FH+ at task 3' intercept 1 FHjohn 0 1 stage 0 0 0 1 
FHjohn*stage 0 0 0 0 0 0 0 0 1/E; 
estimate 'mean pNN50 for FH+ at recovery' intercept 1 FHjohn 0 1 stage 0 0 0 
0 1 FHjohn*stage 0 0 0 0 0 0 0 0 0 1/E; 
estimate 'change from baseline to task 1 for FH-' stage -1 1 0 0 0 
Fhjohn*stage -1 1 0 0 0 0 0 0 0 0/E; 
estimate 'change from baseline to task 2 for FH-' stage -1 0 1 0 0 
Fhjohn*stage -1 0 1 0 0 0 0 0 0 0/E; 
estimate 'change from baseline to task 3 for FH-' stage -1 0 0 1 0 
Fhjohn*stage -1 0 0 1 0 0 0 0 0 0/E; 
estimate 'change from baseline to recovery for FH-' stage -1 0 0 0 1 
Fhjohn*stage -1 0 0 0 1 0 0 0 0 0/E; 
estimate 'change from task 1 to recovery for FH-' stage 0 1 0 0 -1 
FHjohn*stage 0 1 0 0 -1 0 0 0 0 0/E; 
estimate 'change from task 2 to recovery for FH-' stage 0 0 1 0 -1 
FHjohn*stage 0 0 1 0 -1 0 0 0 0 0/E; 
estimate 'change from task 3 to recovery for FH-' stage 0 0 0 1 -1 
FHjohn*stage 0 0 0 1 -1 0 0 0 0 0/E; 
estimate 'change from baseline to task 1 for FH+' stage -1 1 0 0 0 
Fhjohn*stage 0 0 0 0 0 -1 1 0 0 0/E; 
estimate 'change from baseline to task 2 for FH+' stage -1 0 1 0 0 
Fhjohn*stage 0 0 0 0 0 -1 0 1 0 0/E; 
estimate 'change from baseline to task 3 for FH+' stage -1 0 0 1 0 
Fhjohn*stage 0 0 0 0 0 -1 0 0 1 0/E; 
estimate 'change from baseline to recovery for FH+' stage -1 0 0 0 1 
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Fhjohn*stage 0 0 0 0 0 -1 0 0 0 1/E; 
estimate 'change from task 1 to recovery for FH+' stage 0 1 0 0 -1 
FHjohn*stage 0 0 0 0 0 0 1 0 0 -1/E; 
estimate 'change from task 2 to recovery for FH+' stage 0 0 1 0 -1 
FHjohn*stage 0 0 0 0 0 0 0 1 0 -1/E; 
estimate 'change from task 3 to recovery for FH+' stage 0 0 0 1 -1 
FHjohn*stage 0 0 0 0 0 0 0 0 1 -1/E; 
estimate 'diff pNN50 for FH+/- at baseline' FHjohn -1 1 FHjohn*stage -1 0 0 0 
0 1 0 0 0 0 /E; 
estimate 'diff pNN50 for FH+/- at task 1' FHjohn -1 1 FHjohn*stage 0 -1 0 0 0 
0 1 0 0 0 /E; 
estimate 'diff pNN50 for FH+/- at task 2' FHjohn -1 1 FHjohn*stage 0 0 -1 0 0 
0 0 1 0 0 /E; 
estimate 'diff pNN50 for FH+/- at task 3' FHjohn -1 1 FHjohn*stage 0 0 0 -1 0 
0 0 0 1 0 /E; 
estimate 'diff pNN50 for FH+/- at recovery' FHjohn -1 1 FHjohn*stage 0 0 0 0 
-1 0 0 0 0 1 /E; 
estimate 'diff pNN50 change (task 1- baseline) for FH+/-' FHjohn*stage 1 -1 0 
0 0 -1 1 0 0 0 /E; 
estimate 'diff pNN50 change (task 2- baseline) for FH+/-' FHjohn*stage 1 0 -1 
0 0 -1 0 1 0 0 /E; 
estimate 'diff pNN50 change (task 3- baseline) for FH+/-' FHjohn*stage 1 0 0 
-1 0 -1 0 0 1 0 /E; 
estimate 'diff pNN50 change (recovery- baseline) for FH+/-' FHjohn*stage 1 0 
0 0 -1 -1 0 0 0 1 /E; 
estimate 'diff pNN50 change (task 2- task 1) for FH+/-' FHjohn*stage 0 1 -1 0 
0 0 -1 1 0 0 /E; 
estimate 'diff pNN50 change (task 3- task 1) for FH+/-' FHjohn*stage 0 1 0 -1 
0 0 -1 0 1 0 /E; 
estimate 'diff pNN50 change (recovery- task 1) for FH+/-' FHjohn*stage 0 1 0 
0 -1 0 -1 0 0 1 /E; 
estimate 'diff pNN50 change (task 3- task 2) for FH+/-' FHjohn*stage 0 0 1 -1 
0 0 0 -1 1 0/E; 
estimate 'diff pNN50 change (recovery- task 2) for FH+/-' FHjohn*stage 0 0 1 
0 -1 0 0 -1 0 1/E; 
estimate 'diff pNN50 change (recovery- task 3) for FH+/-' FHjohn*stage 0 0 0 
1 -1 0 0 0 -1 1/E; 
run; 
 39 
 
proc mixed data=combine; 
class FHjohn stage id time; 
model SDANN_t=FHjohn stage FHjohn*stage Age race_bin SBMI SBanxiety/solution; 
repeated stage/subject=id type=cs; 
estimate 'mean SDANN for FH- at baseline' intercept 1 FHjohn 1 0 stage 1 
FHjohn*stage 1 0/E; 
estimate 'mean SDANN for FH- at task 1' intercept 1 FHjohn 1 0 stage 0 1 
FHjohn*stage 0 1/E; 
estimate 'mean SDANN for FH- at task 2' intercept 1 FHjohn 1 0 stage 0 0 1 
FHjohn*stage 0 0 1/E; 
estimate 'mean SDANN for FH- at task 3' intercept 1 FHjohn 1 0 stage 0 0 0 1 
FHjohn*stage 0 0 0 1/E; 
estimate 'mean SDANN for FH- at recovery' intercept 1 FHjohn 1 0 stage 0 0 0 
0 1 FHjohn*stage 0 0 0 0 1/E; 
estimate 'mean SDANN for FH+ at baseline' intercept 1 FHjohn 0 1 stage 1 
FHjohn*stage 0 0 0 0 0 1/E; 
estimate 'mean SDANN for FH+ at task 1' intercept 1 FHjohn 0 1 stage 0 1 
FHjohn*stage 0 0 0 0 0 0 1/E; 
estimate 'mean SDANN for FH+ at task 2' intercept 1 FHjohn 0 1 stage 0 0 1 
FHjohn*stage 0 0 0 0 0 0 0 1/E; 
estimate 'mean SDANN for FH+ at task 3' intercept 1 FHjohn 0 1 stage 0 0 0 1 
FHjohn*stage 0 0 0 0 0 0 0 0 1/E; 
estimate 'mean SDANN for FH+ at recovery' intercept 1 FHjohn 0 1 stage 0 0 0 
0 1 FHjohn*stage 0 0 0 0 0 0 0 0 0 1/E; 
estimate 'change from baseline to task 1 for FH-' stage -1 1 0 0 0 
Fhjohn*stage -1 1 0 0 0 0 0 0 0 0/E; 
estimate 'change from baseline to task 2 for FH-' stage -1 0 1 0 0 
Fhjohn*stage -1 0 1 0 0 0 0 0 0 0/E; 
estimate 'change from baseline to task 3 for FH-' stage -1 0 0 1 0 
Fhjohn*stage -1 0 0 1 0 0 0 0 0 0/E; 
estimate 'change from baseline to recovery for FH-' stage -1 0 0 0 1 
Fhjohn*stage -1 0 0 0 1 0 0 0 0 0/E; 
estimate 'change from task 1 to recovery for FH-' stage 0 1 0 0 -1 
FHjohn*stage 0 1 0 0 -1 0 0 0 0 0/E; 
estimate 'change from task 2 to recovery for FH-' stage 0 0 1 0 -1 
FHjohn*stage 0 0 1 0 -1 0 0 0 0 0/E; 
estimate 'change from task 3 to recovery for FH-' stage 0 0 0 1 -1 
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FHjohn*stage 0 0 0 1 -1 0 0 0 0 0/E; 
estimate 'change from baseline to task 1 for FH+' stage -1 1 0 0 0 
Fhjohn*stage 0 0 0 0 0 -1 1 0 0 0/E; 
estimate 'change from baseline to task 2 for FH+' stage -1 0 1 0 0 
Fhjohn*stage 0 0 0 0 0 -1 0 1 0 0/E; 
estimate 'change from baseline to task 3 for FH+' stage -1 0 0 1 0 
Fhjohn*stage 0 0 0 0 0 -1 0 0 1 0/E; 
estimate 'change from baseline to recovery for FH+' stage -1 0 0 0 1 
Fhjohn*stage 0 0 0 0 0 -1 0 0 0 1/E; 
estimate 'change from task 1 to recovery for FH+' stage 0 1 0 0 -1 
FHjohn*stage 0 0 0 0 0 0 1 0 0 -1/E; 
estimate 'change from task 2 to recovery for FH+' stage 0 0 1 0 -1 
FHjohn*stage 0 0 0 0 0 0 0 1 0 -1/E; 
estimate 'change from task 3 to recovery for FH+' stage 0 0 0 1 -1 
FHjohn*stage 0 0 0 0 0 0 0 0 1 -1/E; 
estimate 'diff SDANN for FH+/- at baseline' FHjohn -1 1 FHjohn*stage -1 0 0 0 
0 1 0 0 0 0 /E; 
estimate 'diff SDANN for FH+/- at task 1' FHjohn -1 1 FHjohn*stage 0 -1 0 0 0 
0 1 0 0 0 /E; 
estimate 'diff SDANN for FH+/- at task 2' FHjohn -1 1 FHjohn*stage 0 0 -1 0 0 
0 0 1 0 0 /E; 
estimate 'diff SDANN for FH+/- at task 3' FHjohn -1 1 FHjohn*stage 0 0 0 -1 0 
0 0 0 1 0 /E; 
estimate 'diff SDANN for FH+/- at recovery' FHjohn -1 1 FHjohn*stage 0 0 0 0 
-1 0 0 0 0 1 /E; 
estimate 'diff SDANN change (task 1- baseline) for FH+/-' FHjohn*stage 1 -1 0 
0 0 -1 1 0 0 0 /E; 
estimate 'diff SDANN change (task 2- baseline) for FH+/-' FHjohn*stage 1 0 -1 
0 0 -1 0 1 0 0 /E; 
estimate 'diff SDANN change (task 3- baseline) for FH+/-' FHjohn*stage 1 0 0 
-1 0 -1 0 0 1 0 /E; 
estimate 'diff SDANN change (recovery- baseline) for FH+/-' FHjohn*stage 1 0 
0 0 -1 -1 0 0 0 1 /E; 
estimate 'diff SDANN change (task 2- task 1) for FH+/-' FHjohn*stage 0 1 -1 0 
0 0 -1 1 0 0 /E; 
estimate 'diff SDANN change (task 3- task 1) for FH+/-' FHjohn*stage 0 1 0 -1 
0 0 -1 0 1 0 /E; 
estimate 'diff SDANN change (recovery- task 1) for FH+/-' FHjohn*stage 0 1 0 
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0 -1 0 -1 0 0 1 /E; 
estimate 'diff SDANN change (task 3- task 2) for FH+/-' FHjohn*stage 0 0 1 -1 
0 0 0 -1 1 0/E; 
estimate 'diff SDANN change (recovery- task 2) for FH+/-' FHjohn*stage 0 0 1 
0 -1 0 0 -1 0 1/E; 
estimate 'diff SDANN change (recovery- task 3) for FH+/-' FHjohn*stage 0 0 0 
1 -1 0 0 0 -1 1/E; 
run; 
 
proc mixed data=combine; 
class FHjohn stage id; 
model fftHF_t=FHjohn stage FHjohn*stage Age race_bin SBMI SBanxiety/solution; 
repeated stage/subject=id type=cs; 
estimate 'mean fftHF for FH- at baseline' intercept 1 FHjohn 1 0 stage 1 
FHjohn*stage 1 0/E; 
estimate 'mean fftHF for FH- at task 1' intercept 1 FHjohn 1 0 stage 0 1 
FHjohn*stage 0 1/E; 
estimate 'mean fftHF for FH- at task 2' intercept 1 FHjohn 1 0 stage 0 0 1 
FHjohn*stage 0 0 1/E; 
estimate 'mean fftHF for FH- at task 3' intercept 1 FHjohn 1 0 stage 0 0 0 1 
FHjohn*stage 0 0 0 1/E; 
estimate 'mean fftHF for FH- at recovery' intercept 1 FHjohn 1 0 stage 0 0 0 
0 1 FHjohn*stage 0 0 0 0 1/E; 
estimate 'mean fftHF for FH+ at baseline' intercept 1 FHjohn 0 1 stage 1 
FHjohn*stage 0 0 0 0 0 1/E; 
estimate 'mean fftHF for FH+ at task 1' intercept 1 FHjohn 0 1 stage 0 1 
FHjohn*stage 0 0 0 0 0 0 1/E; 
estimate 'mean fftHF for FH+ at task 2' intercept 1 FHjohn 0 1 stage 0 0 1 
FHjohn*stage 0 0 0 0 0 0 0 1/E; 
estimate 'mean fftHF for FH+ at task 3' intercept 1 FHjohn 0 1 stage 0 0 0 1 
FHjohn*stage 0 0 0 0 0 0 0 0 1/E; 
estimate 'mean fftHF for FH+ at recovery' intercept 1 FHjohn 0 1 stage 0 0 0 
0 1 FHjohn*stage 0 0 0 0 0 0 0 0 0 1/E; 
estimate 'change from baseline to task 1 for FH-' stage -1 1 0 0 0 
Fhjohn*stage -1 1 0 0 0 0 0 0 0 0/E; 
estimate 'change from baseline to task 2 for FH-' stage -1 0 1 0 0 
Fhjohn*stage -1 0 1 0 0 0 0 0 0 0/E; 
estimate 'change from baseline to task 3 for FH-' stage -1 0 0 1 0 
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Fhjohn*stage -1 0 0 1 0 0 0 0 0 0/E; 
estimate 'change from baseline to recovery for FH-' stage -1 0 0 0 1 
Fhjohn*stage -1 0 0 0 1 0 0 0 0 0/E; 
estimate 'change from task 1 to recovery for FH-' stage 0 1 0 0 -1 
FHjohn*stage 0 1 0 0 -1 0 0 0 0 0/E; 
estimate 'change from task 2 to recovery for FH-' stage 0 0 1 0 -1 
FHjohn*stage 0 0 1 0 -1 0 0 0 0 0/E; 
estimate 'change from task 3 to recovery for FH-' stage 0 0 0 1 -1 
FHjohn*stage 0 0 0 1 -1 0 0 0 0 0/E; 
estimate 'change from baseline to task 1 for FH+' stage -1 1 0 0 0 
Fhjohn*stage 0 0 0 0 0 -1 1 0 0 0/E; 
estimate 'change from baseline to task 2 for FH+' stage -1 0 1 0 0 
Fhjohn*stage 0 0 0 0 0 -1 0 1 0 0/E; 
estimate 'change from baseline to task 3 for FH+' stage -1 0 0 1 0 
Fhjohn*stage 0 0 0 0 0 -1 0 0 1 0/E; 
estimate 'change from baseline to recovery for FH+' stage -1 0 0 0 1 
Fhjohn*stage 0 0 0 0 0 -1 0 0 0 1/E; 
estimate 'change from task 1 to recovery for FH+' stage 0 1 0 0 -1 
FHjohn*stage 0 0 0 0 0 0 1 0 0 -1/E; 
estimate 'change from task 2 to recovery for FH+' stage 0 0 1 0 -1 
FHjohn*stage 0 0 0 0 0 0 0 1 0 -1/E; 
estimate 'change from task 3 to recovery for FH+' stage 0 0 0 1 -1 
FHjohn*stage 0 0 0 0 0 0 0 0 1 -1/E; 
estimate 'diff fftHF for FH+/- at baseline' FHjohn -1 1 FHjohn*stage -1 0 0 0 
0 1 0 0 0 0 /E; 
estimate 'diff fftHF for FH+/- at task 1' FHjohn -1 1 FHjohn*stage 0 -1 0 0 0 
0 1 0 0 0 /E; 
estimate 'diff fftHF for FH+/- at task 2' FHjohn -1 1 FHjohn*stage 0 0 -1 0 0 
0 0 1 0 0 /E; 
estimate 'diff fftHF for FH+/- at task 3' FHjohn -1 1 FHjohn*stage 0 0 0 -1 0 
0 0 0 1 0 /E; 
estimate 'diff fftHF for FH+/- at recovery' FHjohn -1 1 FHjohn*stage 0 0 0 0 
-1 0 0 0 0 1 /E; 
estimate 'diff fftHF change (task 1- baseline) for FH+/-' FHjohn*stage 1 -1 0 
0 0 -1 1 0 0 0 /E; 
estimate 'diff fftHF change (task 2- baseline) for FH+/-' FHjohn*stage 1 0 -1 
0 0 -1 0 1 0 0 /E; 
estimate 'diff fftHF change (task 3- baseline) for FH+/-' FHjohn*stage 1 0 0 
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-1 0 -1 0 0 1 0 /E; 
estimate 'diff fftHF change (recovery- baseline) for FH+/-' FHjohn*stage 1 0 
0 0 -1 -1 0 0 0 1 /E; 
estimate 'diff fftHF change (task 2- task 1) for FH+/-' FHjohn*stage 0 1 -1 0 
0 0 -1 1 0 0 /E; 
estimate 'diff fftHF change (task 3- task 1) for FH+/-' FHjohn*stage 0 1 0 -1 
0 0 -1 0 1 0 /E; 
estimate 'diff fftHF change (recovery- task 1) for FH+/-' FHjohn*stage 0 1 0 
0 -1 0 -1 0 0 1 /E; 
estimate 'diff fftHF change (task 3- task 2) for FH+/-' FHjohn*stage 0 0 1 -1 
0 0 0 -1 1 0/E; 
estimate 'diff fftHF change (recovery- task 2) for FH+/-' FHjohn*stage 0 0 1 
0 -1 0 0 -1 0 1/E; 
estimate 'diff fftHF change (recovery- task 3) for FH+/-' FHjohn*stage 0 0 0 
1 -1 0 0 0 -1 1/E; 
run; 
 
proc mixed data=combine; 
class FHjohn stage id time; 
model fftHFnu=FHjohn stage FHjohn*stage Age race_bin SBMI SBanxiety/solution; 
repeated stage/subject=id type=cs; 
estimate 'mean fftHFnu for FH- at baseline' intercept 1 FHjohn 1 0 stage 1 
FHjohn*stage 1 0/E; 
estimate 'mean fftHFnu for FH- at task 1' intercept 1 FHjohn 1 0 stage 0 1 
FHjohn*stage 0 1/E; 
estimate 'mean fftHFnu for FH- at task 2' intercept 1 FHjohn 1 0 stage 0 0 1 
FHjohn*stage 0 0 1/E; 
estimate 'mean fftHFnu for FH- at task 3' intercept 1 FHjohn 1 0 stage 0 0 0 
1 FHjohn*stage 0 0 0 1/E; 
estimate 'mean fftHFnu for FH- at recovery' intercept 1 FHjohn 1 0 stage 0 0 
0 0 1 FHjohn*stage 0 0 0 0 1/E; 
estimate 'mean fftHFnu for FH+ at baseline' intercept 1 FHjohn 0 1 stage 1 
FHjohn*stage 0 0 0 0 0 1/E; 
estimate 'mean fftHFnu for FH+ at task 1' intercept 1 FHjohn 0 1 stage 0 1 
FHjohn*stage 0 0 0 0 0 0 1/E; 
estimate 'mean fftHFnu for FH+ at task 2' intercept 1 FHjohn 0 1 stage 0 0 1 
FHjohn*stage 0 0 0 0 0 0 0 1/E; 
estimate 'mean fftHFnu for FH+ at task 3' intercept 1 FHjohn 0 1 stage 0 0 0 
 44 
1 FHjohn*stage 0 0 0 0 0 0 0 0 1/E; 
estimate 'mean fftHFnu for FH+ at recovery' intercept 1 FHjohn 0 1 stage 0 0 
0 0 1 FHjohn*stage 0 0 0 0 0 0 0 0 0 1/E; 
estimate 'change from baseline to task 1 for FH-' stage -1 1 0 0 0 
Fhjohn*stage -1 1 0 0 0 0 0 0 0 0/E; 
estimate 'change from baseline to task 2 for FH-' stage -1 0 1 0 0 
Fhjohn*stage -1 0 1 0 0 0 0 0 0 0/E; 
estimate 'change from baseline to task 3 for FH-' stage -1 0 0 1 0 
Fhjohn*stage -1 0 0 1 0 0 0 0 0 0/E; 
estimate 'change from baseline to recovery for FH-' stage -1 0 0 0 1 
Fhjohn*stage -1 0 0 0 1 0 0 0 0 0/E; 
estimate 'change from task 1 to recovery for FH-' stage 0 1 0 0 -1 
FHjohn*stage 0 1 0 0 -1 0 0 0 0 0/E; 
estimate 'change from task 2 to recovery for FH-' stage 0 0 1 0 -1 
FHjohn*stage 0 0 1 0 -1 0 0 0 0 0/E; 
estimate 'change from task 3 to recovery for FH-' stage 0 0 0 1 -1 
FHjohn*stage 0 0 0 1 -1 0 0 0 0 0/E; 
estimate 'change from baseline to task 1 for FH+' stage -1 1 0 0 0 
Fhjohn*stage 0 0 0 0 0 -1 1 0 0 0/E; 
estimate 'change from baseline to task 2 for FH+' stage -1 0 1 0 0 
Fhjohn*stage 0 0 0 0 0 -1 0 1 0 0/E; 
estimate 'change from baseline to task 3 for FH+' stage -1 0 0 1 0 
Fhjohn*stage 0 0 0 0 0 -1 0 0 1 0/E; 
estimate 'change from baseline to recovery for FH+' stage -1 0 0 0 1 
Fhjohn*stage 0 0 0 0 0 -1 0 0 0 1/E; 
estimate 'change from task 1 to recovery for FH+' stage 0 1 0 0 -1 
FHjohn*stage 0 0 0 0 0 0 1 0 0 -1/E; 
estimate 'change from task 2 to recovery for FH+' stage 0 0 1 0 -1 
FHjohn*stage 0 0 0 0 0 0 0 1 0 -1/E; 
estimate 'change from task 3 to recovery for FH+' stage 0 0 0 1 -1 
FHjohn*stage 0 0 0 0 0 0 0 0 1 -1/E; 
estimate 'diff fftHFnu for FH+/- at baseline' FHjohn -1 1 FHjohn*stage -1 0 0 
0 0 1 0 0 0 0 /E; 
estimate 'diff fftHFnu for FH+/- at task 1' FHjohn -1 1 FHjohn*stage 0 -1 0 0 
0 0 1 0 0 0 /E; 
estimate 'diff fftHFnu for FH+/- at task 2' FHjohn -1 1 FHjohn*stage 0 0 -1 0 
0 0 0 1 0 0 /E; 
estimate 'diff fftHFnu for FH+/- at task 3' FHjohn -1 1 FHjohn*stage 0 0 0 -1 
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0 0 0 0 1 0 /E; 
estimate 'diff fftHFnu for FH+/- at recovery' FHjohn -1 1 FHjohn*stage 0 0 0 
0 -1 0 0 0 0 1 /E; 
estimate 'diff fftHFnu change (task 1- baseline) for FH+/-' FHjohn*stage 1 -1 
0 0 0 -1 1 0 0 0 /E; 
estimate 'diff fftHFnu change (task 2- baseline) for FH+/-' FHjohn*stage 1 0 
-1 0 0 -1 0 1 0 0 /E; 
estimate 'diff fftHFnu change (task 3- baseline) for FH+/-' FHjohn*stage 1 0 
0 -1 0 -1 0 0 1 0 /E; 
estimate 'diff fftHFnu change (recovery- baseline) for FH+/-' FHjohn*stage 1 
0 0 0 -1 -1 0 0 0 1 /E; 
estimate 'diff fftHFnu change (task 2- task 1) for FH+/-' FHjohn*stage 0 1 -1 
0 0 0 -1 1 0 0 /E; 
estimate 'diff fftHFnu change (task 3- task 1) for FH+/-' FHjohn*stage 0 1 0 
-1 0 0 -1 0 1 0 /E; 
estimate 'diff fftHFnu change (recovery- task 1) for FH+/-' FHjohn*stage 0 1 
0 0 -1 0 -1 0 0 1 /E; 
estimate 'diff fftHFnu change (task 3- task 2) for FH+/-' FHjohn*stage 0 0 1 
-1 0 0 0 -1 1 0/E; 
estimate 'diff fftHFnu change (recovery- task 2) for FH+/-' FHjohn*stage 0 0 
1 0 -1 0 0 -1 0 1/E; 
estimate 'diff fftHFnu change (recovery- task 3) for FH+/-' FHjohn*stage 0 0 
0 1 -1 0 0 0 -1 1/E; 
run; 
 
proc mixed data=combine; 
class FHjohn stage id time; 
model fftLFoverHF_t=FHjohn stage FHjohn*stage Age race_bin SBMI 
SBanxiety/solution; 
repeated stage/subject=id type=cs; 
estimate 'mean fftLFoverHF for FH- at baseline' intercept 1 FHjohn 1 0 stage 
1 FHjohn*stage 1 0/E; 
estimate 'mean fftLFoverHF for FH- at task 1' intercept 1 FHjohn 1 0 stage 0 
1 FHjohn*stage 0 1/E; 
estimate 'mean fftLFoverHF for FH- at task 2' intercept 1 FHjohn 1 0 stage 0 
0 1 FHjohn*stage 0 0 1/E; 
estimate 'mean fftLFoverHF for FH- at task 3' intercept 1 FHjohn 1 0 stage 0 
0 0 1 FHjohn*stage 0 0 0 1/E; 
 46 
estimate 'mean fftLFoverHF for FH- at recovery' intercept 1 FHjohn 1 0 stage 
0 0 0 0 1 FHjohn*stage 0 0 0 0 1/E; 
estimate 'mean fftLFoverHF for FH+ at baseline' intercept 1 FHjohn 0 1 stage 
1 FHjohn*stage 0 0 0 0 0 1/E; 
estimate 'mean fftLFoverHF for FH+ at task 1' intercept 1 FHjohn 0 1 stage 0 
1 FHjohn*stage 0 0 0 0 0 0 1/E; 
estimate 'mean fftLFoverHF for FH+ at task 2' intercept 1 FHjohn 0 1 stage 0 
0 1 FHjohn*stage 0 0 0 0 0 0 0 1/E; 
estimate 'mean fftLFoverHF for FH+ at task 3' intercept 1 FHjohn 0 1 stage 0 
0 0 1 FHjohn*stage 0 0 0 0 0 0 0 0 1/E; 
estimate 'mean fftLFoverHF for FH+ at recovery' intercept 1 FHjohn 0 1 stage 
0 0 0 0 1 FHjohn*stage 0 0 0 0 0 0 0 0 0 1/E; 
estimate 'change from baseline to task 1 for FH-' stage -1 1 0 0 0 
Fhjohn*stage -1 1 0 0 0 0 0 0 0 0/E; 
estimate 'change from baseline to task 2 for FH-' stage -1 0 1 0 0 
Fhjohn*stage -1 0 1 0 0 0 0 0 0 0/E; 
estimate 'change from baseline to task 3 for FH-' stage -1 0 0 1 0 
Fhjohn*stage -1 0 0 1 0 0 0 0 0 0/E; 
estimate 'change from baseline to recovery for FH-' stage -1 0 0 0 1 
Fhjohn*stage -1 0 0 0 1 0 0 0 0 0/E; 
estimate 'change from task 1 to recovery for FH-' stage 0 1 0 0 -1 
FHjohn*stage 0 1 0 0 -1 0 0 0 0 0/E; 
estimate 'change from task 2 to recovery for FH-' stage 0 0 1 0 -1 
FHjohn*stage 0 0 1 0 -1 0 0 0 0 0/E; 
estimate 'change from task 3 to recovery for FH-' stage 0 0 0 1 -1 
FHjohn*stage 0 0 0 1 -1 0 0 0 0 0/E; 
estimate 'change from baseline to task 1 for FH+' stage -1 1 0 0 0 
Fhjohn*stage 0 0 0 0 0 -1 1 0 0 0/E; 
estimate 'change from baseline to task 2 for FH+' stage -1 0 1 0 0 
Fhjohn*stage 0 0 0 0 0 -1 0 1 0 0/E; 
estimate 'change from baseline to task 3 for FH+' stage -1 0 0 1 0 
Fhjohn*stage 0 0 0 0 0 -1 0 0 1 0/E; 
estimate 'change from baseline to recovery for FH+' stage -1 0 0 0 1 
Fhjohn*stage 0 0 0 0 0 -1 0 0 0 1/E; 
estimate 'change from task 1 to recovery for FH+' stage 0 1 0 0 -1 
FHjohn*stage 0 0 0 0 0 0 1 0 0 -1/E; 
estimate 'change from task 2 to recovery for FH+' stage 0 0 1 0 -1 
FHjohn*stage 0 0 0 0 0 0 0 1 0 -1/E; 
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estimate 'change from task 3 to recovery for FH+' stage 0 0 0 1 -1 
FHjohn*stage 0 0 0 0 0 0 0 0 1 -1/E; 
estimate 'diff fftLFoverHF for FH+/- at baseline' FHjohn -1 1 FHjohn*stage -1 
0 0 0 0 1 0 0 0 0 /E; 
estimate 'diff fftLFoverHF for FH+/- at task 1' FHjohn -1 1 FHjohn*stage 0 -1 
0 0 0 0 1 0 0 0 /E; 
estimate 'diff fftLFoverHF for FH+/- at task 2' FHjohn -1 1 FHjohn*stage 0 0 
-1 0 0 0 0 1 0 0 /E; 
estimate 'diff fftLFoverHF for FH+/- at task 3' FHjohn -1 1 FHjohn*stage 0 0 
0 -1 0 0 0 0 1 0 /E; 
estimate 'diff fftLFoverHF for FH+/- at recovery' FHjohn -1 1 FHjohn*stage 0 
0 0 0 -1 0 0 0 0 1 /E; 
estimate 'diff fftLFoverHF change (task 1- baseline) for FH+/-'   
FHjohn*stage  1 -1 0 0 0 -1 1 0 0 0 /E; 
estimate 'diff fftLFoverHF change (task 2- baseline) for FH+/-'   
FHjohn*stage  1 0 -1 0 0 -1 0 1 0 0 /E; 
estimate 'diff fftLFoverHF change (task 3- baseline) for FH+/-'   
FHjohn*stage  1 0 0 -1 0 -1 0 0 1 0 /E; 
estimate 'diff fftLFoverHF change (recovery- baseline) for FH+/-' 
FHjohn*stage  1 0 0 0 -1 -1 0 0 0 1 /E; 
estimate 'diff fftLFoverHF change (task 2- task 1) for FH+/-'     
FHjohn*stage  0 1 -1 0 0 0 -1 1 0 0 /E; 
estimate 'diff fftLFoverHF change (task 3- task 1) for FH+/-'     
FHjohn*stage  0 1 0 -1 0 0 -1 0 1 0 /E; 
estimate 'diff fftLFoverHF change (recovery- task 1) for FH+/-'   
FHjohn*stage  0 1 0 0 -1 0 -1 0 0 1 /E; 
estimate 'diff fftLFoverHF change (task 3- task 2) for FH+/-'     
FHjohn*stage  0 0 1 -1 0 0 0 -1 1 0/E; 
estimate 'diff fftLFoverHF change (recovery- task 2) for FH+/-'   
FHjohn*stage  0 0 1 0 -1 0 0 -1 0 1/E; 
estimate 'diff fftLFoverHF change (recovery- task 3) for FH+/-'   
FHjohn*stage  0 0 0 1 -1 0 0 0 -1 1/E; 
run; 
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